CD95-Dependent Bystander Lysis Caused by CD4+ T Helper 1 Effectors

Journal of Immunology

Volumn 157, Issue 7, 1996, Pages 2961-2968

  Wang, Ruduan ^a   Rogers, Amy M ^a   Ratliff, Timothy L ^a   Russell, John H ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FAS ANTIGEN; FAS LIGAND; FASL PROTEIN, MOUSE; GAMMA INTERFERON; MEMBRANE PROTEIN; RECOMBINANT PROTEIN;

ANIMAL; ANTIBODY SPECIFICITY; ANTIGEN PRESENTING CELL; ARTICLE; BAGG ALBINO MOUSE; BIOSYNTHESIS; C57BL MOUSE; CELL CULTURE; CELL LINE; COCULTURE; COMPARATIVE STUDY; CYTOLOGY; CYTOTOXICITY; GENETIC TRANSFECTION; GENETICS; IMMUNOLOGY; INFLAMMATION; INTERSTITIAL CYSTITIS; L CELL; LYMPHOCYTE ACTIVATION; LYMPHOMA; METABOLISM; MOUSE; MOUSE MUTANT; PATHOLOGY; PERITONEUM MACROPHAGE; PHYSIOLOGY; SECRETION; TH1 CELL; UROTHELIUM;

ANIMALS; ANTIGEN-PRESENTING CELLS; ANTIGENS, CD95; CELL LINE, TRANSFORMED; CELLS, CULTURED; COCULTURE TECHNIQUES; CYSTITIS, INTERSTITIAL; CYTOTOXICITY, IMMUNOLOGIC; FAS LIGAND PROTEIN; INFLAMMATION; INTERFERON TYPE II; L CELLS (CELL LINE); LYMPHOCYTE ACTIVATION; LYMPHOMA; MACROPHAGES, PERITONEAL; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; ORGAN SPECIFICITY; RECOMBINANT PROTEINS; TH1 CELLS; TRANSFECTION; TUMOR CELLS, CULTURED; UROTHELIUM;

EID: 0030267419     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. + lymphocytes delete activated macrophages through the Fas/APO-1 antigen pathway. Proc. Natl. Acad. Sci. USA 92:11225.
2. Fall, M., S. L. Johansson, and F. Aldenborg. 1987. Chronic interstitial cystitis: a heterogeneous syndrome. J. Urol. 137:35.
3. Harrington, D. S., M. Fall, and S. L. Johansson. 1990. Interstitial cystitis: bladder mucosa lymphocyte immunophenotyping and peripheral blood flow cytometry analysis. J. Urol. 144:868.
4. Ratner, V., D. Slade, and G. Greene. 1994. Interstitial cystitis: a patient's perspective. Urol. Clin. North Am. 21:1.
5. Liebert, M., G. Wedemeyer, J. A. Stein, R. Washington, Jr., G. Faerber, A. Flint, and H. B. Grossman. 1993. Evidence for urothelial cell activation in interstitial cystitis. J. Urol. 149:470.
6. Henkart, M. P., and P. A. Henkart. 1982. Lymphocyte mediated cytolysis as a secretory phenomenon. Adv. Exp. Med. Biol. 146:227.
7. Henkart, P. A., and C. C. Yue. 1988. The role of cytoplasmic granules in lymphocyte cytotoxicity. Prog. Allergy 40:44.
8. Young, J. D., Z. A. Cohn, and E. R. Podack. 1986. The ninth component of complement and the pore-forming protein (perform 1) from cytotoxic T cells: structural, immunological and functional similarities. Science 233:184.
9. Kägi, D., B. Ledermann, K. Burki, P. Seiler, B. Odermatt, K. J. Olsen, E. R. Podack, R. M. Zinkernagel, and H. Hengartner. 1994. Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice. Nature 369:31
10. Heusel, J. W., R. L. Wesselschmidt, S. Shresta, J. H. Russell, and T. J. Ley. 1994. Cytotoxic lymphocytes require granzyme B for the rapid induction of DNA fragmentation and apoptosis in allogeneic target cells. Cell 76:977.
11. Russell, J. H. 1983. Internal disintegration model of cytotoxic lymphocyte-mediated target damage. Immunol. Rev. 72:97.
12. Tile, J. P., M. B. Powell, and N. H. Ruddle. 1985. Protein-antigen specific Ia-restricted cytolytic T cells: analysis of frequency, target cell susceptibility, and mechanism of cytolysis. J. Immunol. 135:25.
13. ++-independent T cell-mediated cytotoxicity. J. Exp. Med. 177:195.
14. Kägi, D., F. Vignaux, B. Ledermann, K. Burki, V. Depraetere, S. Nagata, H. Hengartner, and P. Golstein. 1994. Fas and perform pathways as major mechanisms of T cell mediated cytotoxicity. Science 265:528.
15. Lowin, B., M. Hahne, C. Mattmann, and J. Tschopp. 1994. Cytolytic T cell cytotoxicity is mediated through perforin and fas lytic pathways. Nature 370:650.
16. Kojima, H., N. Shinohara, S. Hanaoka, Y. Someya-Shirota, Y. Takagaki, H. Ohno, T. Saito, T. Katayama, H. Yagita, K. Okumura, Y. Shinkai, F. W. Alt, A. Matsuzawa, S. Yonehara, and H. Takayama. 1994. Two distinct pathways of specific killing revealed by perforin mutant cytotoxic T lymphocytes. Immunity 1:357.
17. + T cell-mediated cytotoxicity. J. Immunol. 152:1127.
18. + cytotoxic cells. Proc. Natl. Acad. Sci. USA 91:4185.
19. Tanaka, M., T. Suda, T. Takahashi, and S. Nagata. 1995. Expression of the functional soluble form of human fas ligand in activated lymphocytes. EMBO J. 14:1129.
20. Cseh, K., and B. Beutler. 1989. Alternative cleavage of the cachectin/tumor necrosis factor propeptide results in a larger, inactive form of secreted protein. J. Biol. Chem. 264:16256.
21. Summerhayes, I. C., N. J. Bradley, A. D. Joyce, and P. M. Malone. 1988. Transplantation of immortalized bladder epithelial cell lines in denuded mouse bladder. J. Urol. 139:405.
22. Joyce, A. D., K. M. Bulovas, and I. C. Summerhayes. 1988. The subrenal capsule: an alternative site for the maintenance of normal and preneoplastic urothelium. J. Urol. 140:1067.
23. + T lymphocyte-induced target cell detachment: a model for T cell-mediated lytic and nonlytic inflammatory processes. J. Immunol. 146:405.
24. Takashi, R., M. Tanaka, C. I. Brannan, N. A. Jenkins, N. G. Copeland, T. Suda, and S. Nagata. 1994. Generalized lymphoproliferative disease in mice caused by a point mutation in the Fas ligand. Cell 76:969.
25. + T cells is regulated by the antigen-presenting cell. J. Immunol. 150:3832.
26. Russell, J. H., B. J. Rush, S. I. Abrams, and R. Wang. 1992. Sensitivity of T-cells to anti-CD3-stimulated suicide is independent of functional phenotype. Eur. J. Immunol. 22:1655.
27. Ogasawara, J., R. Watanabe-Fukunaga, M. Adachi, A. Matsuzawa, T. Kasugai, Y Kitamura, N. Itoh, T. Suda, and S. Nagata. 1993. Lethal effect of the anti-fas antibody in mice. Nature 364:806.
28. Köhler, G., K. Fischer-Lindahl, and C. Heuser. 1981. In The Immune System. Vol. 2. C. Steinberg and I. Lefkovits, eds, Karger, Basel, pp. 202-208.
29. b haplotype reveal genetic control of isotype expression. J. Immunol. 126:317.
30. Sheehan, K. C. F., N. H. Ruddle, and R. D. Schreiber. 1989. Generation and characterization of hamster monoclonal antibodies that neutralize murine tumor necrosis factors. J. Immunol. 142:3884.
31. Leithäuser, F., J. Dhein, G. Mechtersheimer, K. Koretz, S. Bruderlein, C. Henne, A. Schmidt, K.-M. Debatin, P. H. Krammer, and P. Möller. 1993. Constitutive and induced expression of APO-1, a new member of the nerve growth factor/ tumor necrosis factor receptor superfamily, in normal and neoplastic cells. Lab. Invest. 69:415.
32. Anel, A., M. Buferne, C. Boyer, A.-M. Schmitt-Verhulst, and P. Golstein. 1994. T cell receptor-induced Fas ligand expression in cytotoxic T lymphocyte clones is blocked by protein tyrosine kinase inhibitors and cyclosporin A. Eur. J. Immunol. 24:2469.
33. Yoneharra, S., A. Ishii, and M. Yonehara. 1989. A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor. J. Exp. Med. 169:1747.
34. Ando, D. G., J. Clayton, D. Kono, J. L. Ruban, and E. E. Sercarz. 1989. Encephalitogenic T cells in the B10.PL model of experimental allergic encephalomyelitis (EAE) are of the Th-1 lymphokine subtype. Cell. Immunol. 124:132.
35. McCarron, R. M., M. Racke, M. Spatz, and D. E. McFarlin. 1991. Cerebral vascular endothelial cells are effective targets for in vitro lysis by encephalitogenic T lymphocytes. J. Immunol. 147:503.